Ethylmethylhydroxypyridine Succinate

N/A

Report date: 2025/03/12 15:12:44

Base Information

Drug NameEthylmethylhydroxypyridine Succinate
Drug Alias NameEmoxipinEmoxypine succinateMexidol3-HP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 modulators
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsIschemic StrokeAttention Deficit Disorder with HyperactivityAnxiety Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUzbekistanRussian FederationKazakhstan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRussian Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesPharmasoft Inc
Inactive CompaniesN/A
Active IndicationsIschemic StrokeGlaucoma, Open-Angle
Inactive IndicationsAttention Deficit Disorder with HyperactivityAnxiety DisordersBrain Ischemia

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank